Cargando…

Identification of Novel Autoantigen in the Synovial Fluid of Rheumatoid Arthritis Patients Using an Immunoproteomics Approach

Rheumatoid arthritis (RA) is a chronic, autoimmune and inflammatory joint disease with a poorly understood etiology. Despite widespread diagnostic use of anti-citrullinated protein antibodies and rheumatoid factor proteins there is a strong demand for novel serological biomarkers to improve the diag...

Descripción completa

Detalles Bibliográficos
Autores principales: Biswas, Sagarika, Sharma, Saurabh, Saroha, Ashish, Bhakuni, D. S., Malhotra, Rajesh, Zahur, Muzna, Oellerich, Michael, Das, Hasi R., Asif, Abdul R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572018/
https://www.ncbi.nlm.nih.gov/pubmed/23418544
http://dx.doi.org/10.1371/journal.pone.0056246
_version_ 1782259256191352832
author Biswas, Sagarika
Sharma, Saurabh
Saroha, Ashish
Bhakuni, D. S.
Malhotra, Rajesh
Zahur, Muzna
Oellerich, Michael
Das, Hasi R.
Asif, Abdul R.
author_facet Biswas, Sagarika
Sharma, Saurabh
Saroha, Ashish
Bhakuni, D. S.
Malhotra, Rajesh
Zahur, Muzna
Oellerich, Michael
Das, Hasi R.
Asif, Abdul R.
author_sort Biswas, Sagarika
collection PubMed
description Rheumatoid arthritis (RA) is a chronic, autoimmune and inflammatory joint disease with a poorly understood etiology. Despite widespread diagnostic use of anti-citrullinated protein antibodies and rheumatoid factor proteins there is a strong demand for novel serological biomarkers to improve the diagnosis this disease. The present study was aimed to identify novel autoantigens involved in rheumatoid arthritis (RA) pathogenesis through immune-proteomic strategy. Synovial fluid samples from clinically diagnosed RA patients were separated on two-dimensional gel electrophoresis (2-DE). Samples from patients with non-RA rheumatisms (osteoarthritis and trauma) were used as controls. Immunoreactive proteins were spotted by Western blotting followed by identification through Q-TOF mass spectrometer analysis. Forty Western blots were generated using plasma from ten individual RA patients and 33 reactive spots were identified, 20 from the high molecular weight (HMW) gel and 13 from the low molecular weight (LMW) gel. Among the 33 common immunogenic spots, 18 distinct autoantigens were identified, out of which 14 are novel proteins in this context. Expression analysis of five important proteins, vimentin, gelsolin, alpha 2 HS glycoprotein (AHSG), glial fibrillary acidic protein (GFAP), and α1B-glycoprotein (A1BG) by Western blot analysis using their specific antibodies revealed their higher expression in RA synovial fluid as compared to non-RA samples. Recombinantly expressed GFAP and A1BG protein were used to develop an in-house ELISA to quantify the amount of autoantibodies in the RA patients. RA patients revealed an increase in the expression of GFAP and A1BG in the plasma as compared to osteoarthritis patients. Therefore, GFAP and A1BG can be proposed as potential new autoantigens of diagnostic importance for RA subjects. Further characterization of these proteins in rheumatoid arthritis will be helpful in understanding the role of these proteins in the disease pathogenesis providing new diagnostic tool with better specificity and accurate detection of the disease.
format Online
Article
Text
id pubmed-3572018
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-35720182013-02-15 Identification of Novel Autoantigen in the Synovial Fluid of Rheumatoid Arthritis Patients Using an Immunoproteomics Approach Biswas, Sagarika Sharma, Saurabh Saroha, Ashish Bhakuni, D. S. Malhotra, Rajesh Zahur, Muzna Oellerich, Michael Das, Hasi R. Asif, Abdul R. PLoS One Research Article Rheumatoid arthritis (RA) is a chronic, autoimmune and inflammatory joint disease with a poorly understood etiology. Despite widespread diagnostic use of anti-citrullinated protein antibodies and rheumatoid factor proteins there is a strong demand for novel serological biomarkers to improve the diagnosis this disease. The present study was aimed to identify novel autoantigens involved in rheumatoid arthritis (RA) pathogenesis through immune-proteomic strategy. Synovial fluid samples from clinically diagnosed RA patients were separated on two-dimensional gel electrophoresis (2-DE). Samples from patients with non-RA rheumatisms (osteoarthritis and trauma) were used as controls. Immunoreactive proteins were spotted by Western blotting followed by identification through Q-TOF mass spectrometer analysis. Forty Western blots were generated using plasma from ten individual RA patients and 33 reactive spots were identified, 20 from the high molecular weight (HMW) gel and 13 from the low molecular weight (LMW) gel. Among the 33 common immunogenic spots, 18 distinct autoantigens were identified, out of which 14 are novel proteins in this context. Expression analysis of five important proteins, vimentin, gelsolin, alpha 2 HS glycoprotein (AHSG), glial fibrillary acidic protein (GFAP), and α1B-glycoprotein (A1BG) by Western blot analysis using their specific antibodies revealed their higher expression in RA synovial fluid as compared to non-RA samples. Recombinantly expressed GFAP and A1BG protein were used to develop an in-house ELISA to quantify the amount of autoantibodies in the RA patients. RA patients revealed an increase in the expression of GFAP and A1BG in the plasma as compared to osteoarthritis patients. Therefore, GFAP and A1BG can be proposed as potential new autoantigens of diagnostic importance for RA subjects. Further characterization of these proteins in rheumatoid arthritis will be helpful in understanding the role of these proteins in the disease pathogenesis providing new diagnostic tool with better specificity and accurate detection of the disease. Public Library of Science 2013-02-13 /pmc/articles/PMC3572018/ /pubmed/23418544 http://dx.doi.org/10.1371/journal.pone.0056246 Text en © 2013 Biswas et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Biswas, Sagarika
Sharma, Saurabh
Saroha, Ashish
Bhakuni, D. S.
Malhotra, Rajesh
Zahur, Muzna
Oellerich, Michael
Das, Hasi R.
Asif, Abdul R.
Identification of Novel Autoantigen in the Synovial Fluid of Rheumatoid Arthritis Patients Using an Immunoproteomics Approach
title Identification of Novel Autoantigen in the Synovial Fluid of Rheumatoid Arthritis Patients Using an Immunoproteomics Approach
title_full Identification of Novel Autoantigen in the Synovial Fluid of Rheumatoid Arthritis Patients Using an Immunoproteomics Approach
title_fullStr Identification of Novel Autoantigen in the Synovial Fluid of Rheumatoid Arthritis Patients Using an Immunoproteomics Approach
title_full_unstemmed Identification of Novel Autoantigen in the Synovial Fluid of Rheumatoid Arthritis Patients Using an Immunoproteomics Approach
title_short Identification of Novel Autoantigen in the Synovial Fluid of Rheumatoid Arthritis Patients Using an Immunoproteomics Approach
title_sort identification of novel autoantigen in the synovial fluid of rheumatoid arthritis patients using an immunoproteomics approach
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572018/
https://www.ncbi.nlm.nih.gov/pubmed/23418544
http://dx.doi.org/10.1371/journal.pone.0056246
work_keys_str_mv AT biswassagarika identificationofnovelautoantigeninthesynovialfluidofrheumatoidarthritispatientsusinganimmunoproteomicsapproach
AT sharmasaurabh identificationofnovelautoantigeninthesynovialfluidofrheumatoidarthritispatientsusinganimmunoproteomicsapproach
AT sarohaashish identificationofnovelautoantigeninthesynovialfluidofrheumatoidarthritispatientsusinganimmunoproteomicsapproach
AT bhakunids identificationofnovelautoantigeninthesynovialfluidofrheumatoidarthritispatientsusinganimmunoproteomicsapproach
AT malhotrarajesh identificationofnovelautoantigeninthesynovialfluidofrheumatoidarthritispatientsusinganimmunoproteomicsapproach
AT zahurmuzna identificationofnovelautoantigeninthesynovialfluidofrheumatoidarthritispatientsusinganimmunoproteomicsapproach
AT oellerichmichael identificationofnovelautoantigeninthesynovialfluidofrheumatoidarthritispatientsusinganimmunoproteomicsapproach
AT dashasir identificationofnovelautoantigeninthesynovialfluidofrheumatoidarthritispatientsusinganimmunoproteomicsapproach
AT asifabdulr identificationofnovelautoantigeninthesynovialfluidofrheumatoidarthritispatientsusinganimmunoproteomicsapproach